CATEGORIES

Editors Choice

LATEST

TRENDING

EDITORS CHOICE

Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug

This article was published orginally in Fortune and is authored by Arthur Allen and republished with permission from KHN (@khnews). The drug industry, patient advocates,...

Primary Care for the Sickest of the Sick

Comprehensive Care Improves Health Yet Reduces Total Costs

Groundbreaking Study Reveals Single LSD Dose Offers Instant and Sustained Anxiety Relief

After yielding promising results in a clinical trial, an LSD formulation aimed at treating generalized anxiety disorder has been awarded Breakthrough Therapy status by the U.S. Food and Drug Administration.

Beyond the Tech: The Most Important Leadership Priority in the Age of AI

We live in the advent of AI, and its impact on industries is just starting. Leaders must navigate these changes while keeping first things...